-transparent.png){kind=logo}
Interleukin-1 (IL-1) treatment of synovial cells from rheumatoid arthritis and osteoarthritis patients resulted in a dose-dependent secretion of phospholipase A2 (PLA2). IL-1 also stimulated prostaglandin E2 and plasminogen activator synthesis, in parallel with PLA2 activation; all 3 were detectable within 6 hours of IL-1 treatment and peaked by 24 hours. Synovial cell PLA2 required calcium (5 mM) and a neutral pH (7.5) for maximal activity and appears similar to the PLA2 in synovial fluid, which has been described previously. We conclude that PLA2 can be induced by IL-1, and its secretion may contribute significantly to the inflammatory actions of IL-1.
Related Publications
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
April 1992,
Biochemical and biophysical research communications,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
November 1994,
European journal of biochemistry,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
March 1990,
Biochemical and biophysical research communications,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
March 1996,
The Journal of rheumatology,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
January 1988,
The Journal of rheumatology,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
February 1995,
Biochemistry and molecular biology international,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
January 1996,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
October 1997,
The Biochemical journal,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
February 1994,
Journal of medicinal chemistry,
S C Gilman, and
J Chang, and
P R Zeigler, and
J Uhl, and
E Mochan
January 1993,
Andrologia,
